06 Oct Date October 6, 2020 Categories News Phase 2 human clinical trial shows that metabolic activators reduces recovery time in COVID-19 patients by nearly 30% ScandiBio Therapeutics has completed a Phase II study based on treatment of patients with COVID-19. Patients with mild-to-moderate...
24 Jul Date July 24, 2020 Categories News A review article has been published discussing the current status of COVID-19 therapies A review paper has been published in the journal iScience about the use of drug repositioning applications in treatment of COVID-1...
08 Jul Date July 8, 2020 Categories News A review article has been published regarding the host-microbiome interactions in neurodegenerative diseases A review paper has been published in the journal Frontiers in Neuroscience discussing the use of AI-based systems biology approach...
01 Jun Date June 1, 2020 Categories News ScandiBio Therapeutics has completed a directed share issue amounting to 5 million SEK The Board of Directors of ScandiBio Therapeutics has, in accordance with the issue authorization granted by the extraordinary gene...
19 May Date May 19, 2020 Categories News A review article has been published about the use of AI-based systems biology for drug development to treat neurodegenerative diseases A review paper has been published in the journal Drug Discovery Today discussing the use of systems biology approaches for studyin...
15 May Date May 15, 2020 Categories News A phase II study in COVID-19 patients using CMCS been initiated ScandiBio Therapeutics has initiated a Phase II study in patients with COVID-19 using Combined Metabolic Cofactors Supplementation...
27 Apr Date April 27, 2020 Categories News The results of a phase I study of CMCS have been published The results of a Phase I study have been published in the journal Molecular Systems Biology describing the kinetics of the Combine...
23 Mar Date March 23, 2020 Categories News An article has been published how to address the heterogeneity in liver diseases with AI-based genome metabolic modeling An article has been published in Briefings in Bioinformatics about the heterogeneity in liver diseases. The abnormalities in human...
03 Feb Date February 3, 2020 Categories News A phase II study in patients with Alzheimer’s and Parkinson’s Diseases has been initiated ScandiBio Therapeutics has initiated a Phase II study in patients with Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) u...
15 Jan Date January 15, 2020 Categories News A phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) has been initiated ScandiBio Therapeutics has initiated a Phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) using Combined M...